ro 22-4839 has been researched along with Muscle Contraction in 1 studies
*Muscle Contraction: A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koyama, K; Kuwahara, T; Nakamura, K; Okada, T; Takeuchi, T; Yajima, T; Yoshizaki, H | 1 |
1 other study(ies) available for ro 22-4839 and Muscle Contraction
| Article | Year |
|---|---|
Spasmolytic action of the cerebral circulation improver 6,7-dimethoxy-1- (3,4-dimethoxybenzyl)-4-[( 4-(2-methoxyphenyl)-1-piperazinyl]methyl) isoquinoline in isolated canine vessels.
Topics: Action Potentials; Adrenergic alpha-Antagonists; Animals; Arteries; Calcium; Cerebrovascular Circulation; Dinoprost; Dogs; Female; In Vitro Techniques; Isoquinolines; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Papillary Muscles; Parasympatholytics; Potassium; Prostaglandins F; Serotonin Antagonists | 1987 |